Track topics on Twitter Track topics that are important to you
Anokion (“Anokion” or the “Company”), a privately held biopharmaceutical company developing novel tolerance-inducing therapeutics for autoimmune diseases, today announced ...
Stephan Kontos, Ph.D., promoted to Chief Scientific Officer Tony Rossomando, Ph.D., appointed Vice President, Technical Operations Anokion (“Anokion” or the “Co...
Anokion, a spin-off from the Ecole Polytechnique FÃ©dÃ©rale de Lausanne (EPFL), is focused on applying the companyâs antigen-specific immune tolerance technology to treat...
We have published hundreds of Anokion SA news stories on BioPortfolio along with dozens of Anokion SA Clinical Trials and PubMed Articles about Anokion SA for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Anokion SA Companies in our database. You can also find out about relevant Anokion SA Drugs and Medications on this site too.